Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06129487 · ClinicalTrials.gov registry record · NA
Evaluations of Alcohol Warning Labels
A NA study of Esophageal Cancer and Alcohol Drinking, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 1,053
- Enrollment target
- 1
- Study location
NCT06129487 is a NA study of Esophageal Cancer and Alcohol Drinking that has completed, run by University of Connecticut. The registered enrollment target is 1,053 participants, above the 491-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (114% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06129487, a NA study of Esophageal Cancer and Alcohol Drinking, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,053 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the effectiveness of pictorial warning labels (PWLs) featuring narrative (vs. non-narrative) content in communicating the cancer risk of alcohol. Participants will be randomized to view either three narrative or non-narrative PWLs. Key outcome variables include visual attention, message reactance, risk perceptions, and intentions to reduce and stop drinking.
Conditions Studied
Interventions
- BEHAVIORAL Narrative pictorial warning labels for alcoholic beverages
- BEHAVIORAL Non-narrative pictorial warning labels for alcoholic beverages
Study Locations (1)
Connecticut
- Online Survey-Experiment - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,053 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2024-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06129487
The ClinicalTrials.gov registry entry for NCT06129487 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,053 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 491-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (114% higher). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Narrative pictorial warning labels for alcoholic beverages is the first listed.
NCT06129487 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06129487 about?
NCT06129487 is a clinical study titled "Evaluations of Alcohol Warning Labels". The goal of this study is to determine the effectiveness of pictorial warning labels (PWLs) featuring narrative (vs. non-narrative) content in communicating the cancer risk of alcohol. Participants will be randomized to view either three narrative or non-narrative PWLs. Key outcome variables include...
What is the current status of trial NCT06129487?
This trial is currently completed. It is a NA study. The enrollment target is 1,053 participants. The study started on 2024-01-19. Estimated completion is 2024-03-27.
What conditions does trial NCT06129487 study?
This clinical trial studies the following conditions: Esophageal Cancer, Alcohol Drinking, Oral Cancer, Larynx Cancer.
What interventions are being tested in trial NCT06129487?
The interventions under investigation include: Narrative pictorial warning labels for alcoholic beverages (BEHAVIORAL), Non-narrative pictorial warning labels for alcoholic beverages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06129487?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06129487 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
RECRUITING · NA
-
Exercise Prehabilitation for Locoregional Esophageal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.